Advertisement
Brief report| Volume 32, ISSUE 6, P543-548, September 15, 1992

Intravenous cocaine challenges during naltrexone maintenance: A preliminary study

      This paper is only available as a PDF. To read, Please Download here.

      References

        • Bain G.T.
        • Kornetsky C.
        Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.
        Life Sci. 1987; 40: 1119-1125
        • Byck R.
        Peptide transmitters: a unifying hypothesis for euphoria, respiration, sleep and the action of lithium.
        Lancet. 1976; 2: 72-73
        • Byck R.
        • Ruskis A.
        • Ungerer J.
        • Jatlow P.
        Naloxone potentiates cocaine effect in man.
        Psychopharmacol Bull. 1982; 18: 214-215
        • Carroll M.E.
        • Lac S.T.
        • Walker M.J.
        • Kraagh R.
        • Newman T.
        Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation.
        J Pharmacol Exp Ther. 1986; 238: 1-7
        • DeVry J.
        • Donselaar I.
        • VanRee J.M.
        Food deprivation and acquisition of intravenous cocaine self-administration in rats: Effect of naltrexone and haloperidol.
        J Pharmacol Exp Ther. 1989; 251: 735-740
        • Farrell P.A.
        • Ebert T.J.
        • Kampine J.P.
        Naloxone augments muscle sympathetic nerve activity during isometric exercise in humans.
        Am J Physiol. 1991; 260: E379-388
        • Feria M.
        • Alvarez C.
        • Dominguez J.
        • Sanchez A.
        • Boada J.
        Naloxone potentiation of cardiovascular response to sympathomimetic amines in the rat.
        J Pharmacol Exp Ther. 1990; 255: 523-528
        • Jatlow P.I.
        • Nadim H.
        Determination of cocaine concentrations in plasma by high performance liquid chromatography.
        Clin Chemistry. 1990; 36: 1436-1439
        • Killian A.K.
        • Bonese K.
        • Schuster C.R.
        The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey.
        Drug Alcohol Depend. 1978; 3: 243-251
        • Kosten T.A.
        • Marby D.A.
        • Nestler E.J.
        Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment.
        Life Sci. 1991; 49: PL201-206
      1. Kosten TR, Gawin FH, Fleming J, Silverman DG, Compton M, Jatlow P, Byck R. (in press) Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology.

        • Kosten T.R.
        • Kleber H.D.
        • Morgan C.H.
        Role of opioid antagonists in treating intravenous cocaine abuse.
        Life Sci. 1989; 44: 887-892
        • Mello N.K.
        • Mendelson J.H.
        • Bree M.P.
        • Lukas S.E.
        Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.
        J Pharmacol Exp Ther. 1990; 254: 926-939
        • Morris M.
        • Salmon P.
        • Steinberg H.
        • Sykes E.A.
        Endogenous opioids modulate the cardiovascular response to mental stress.
        Psychoneuroendocrinology. 1990; 15: 185-192
        • Ramsey N.F.
        • van Ree J.M.
        Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats.
        Pharmacol Biochem Behavior. 1991; 40: 807-810
        • VanDyke C.
        • Ungerer J.
        • Jatlow P.
        • Barash P.
        • Byck R.
        Intranasal cocaine dose relationships of psychological effects and plasma levels.
        Int J Psychiatry Med. 1982; 12: 1-13